Eli Lilly and

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$13,532,800
$11,439,100
$11,302,800
$8,768,000
Gross Profit
11,129,000
9,268,300
9,132,600
7,233,600
EBITDA
6,148,800
2,247,900
4,115,200
3,116,300
EBIT
5,682,000
1,781,100
3,700,800
2,715,700
Net Income
4,409,800
970,300
2,967,000
2,242,900
Net Change In Cash
13,532,800
11,439,100
11,302,800
8,768,000
Free Cash Flow
726,600
-458,900
63,400
179,700
Cash
3,268,400
3,369,000
3,223,600
2,460,200
Basic Shares
903,158
905,000
904,200
903,802

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$45,042,700
$34,124,100
$28,541,400
$28,318,400
Gross Profit
36,624,400
27,041,900
21,911,600
21,005,600
EBITDA
15,227,600
8,567,800
8,660,500
8,042,900
EBIT
13,461,000
7,040,500
7,138,000
6,495,300
Net Income
10,590,000
5,240,400
6,244,800
5,581,700
Net Change In Cash
45,042,700
34,124,100
28,541,400
28,318,400
Cost of Revenue
-1,583,900
Free Cash Flow
414,300
-3,152,000
4,600,400
5,387,500
Cash
3,268,400
2,818,600
2,067,000
3,818,500
Basic Shares
904,059
903,284
904,619
911,681

Earnings Calls

Quarter EPS
2024-12-31
$5.32
2024-09-30
$1.18
2024-06-30
$3.92
2024-03-31
$2.58